levonorgestrel has been researched along with Prediabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Michael, OS; Olatunji, LA | 1 |
| Hammond, C; Kiley, JW; Liu, D; Niznik, C; Rademaker, A; Shulman, LP | 1 |
2 other study(ies) available for levonorgestrel and Prediabetes
| Article | Year |
|---|---|
Ameliorative effect of nicotine exposure on insulin resistance is accompanied by decreased cardiac glycogen synthase kinase-3 and plasminogen activator inhibitor-1 during oral oestrogen-progestin therapy.
Topics: Administration, Oral; Aldosterone; Animals; Biomarkers; Cardiovascular Diseases; Contraceptives, Oral, Combined; Corticosterone; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Glycogen Synthase Kinase 3; Heart; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Levonorgestrel; Myocardium; Nicotine; Nicotinic Agonists; Plasminogen Activator Inhibitor 1; Prediabetic State; Random Allocation; Rats, Wistar | 2018 |
Postpartum glucose tolerance in women with gestational diabetes using levonorgestrel intrauterine contraception.
Topics: Adult; Chicago; Contraceptive Agents, Female; Diabetes, Gestational; Female; Follow-Up Studies; Glucose Intolerance; Glucose Tolerance Test; Hospitals, University; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Postpartum Period; Prediabetic State; Pregnancy; Risk; Sterilization, Tubal; Young Adult | 2015 |